Could Ozempic Lower Breast Cancer Risk? What to Know
By
Katie Berohn
Source
ELLECould Ozempic Lower Breast Cancer Risk? What to Knowelle.comYou might also wanna read
Two Observational Studies Link GLP-1 Receptor Agonists to Reduced Breast Cancer Risk in Women with Obesity
Two observational studies found that GLP-1 receptor agonists (like Ozempic, Wegovy) are associated with reduced breast cancer incidence in w
mdsc.pe·9d ago
Weight-Loss Drugs Like Ozempic Shift Societal Attitudes on Body Image and Weight Loss
The article discusses how weight-loss drugs like Ozempic are changing societal attitudes toward body image and weight loss. It presents a ca
wsj.com·6mo ago
Clinical Trial Finds Ozempic Reverses Biological Age by 3.1 Years
The diabetes drug Ozempic has shown significant anti-aging effects in a clinical trial, reversing biological age by an average of 3.1 years
trial.medpath.com·11mo ago
Study Finds Ozempic Does Not Slow Alzheimer's Disease Progression
Novo Nordisk announced that its popular weight-loss drug Ozempic does not slow the progression of Alzheimer's disease, based on results from
semafor.com·7mo ago
Study: Ozempic and Wegovy Reduce Household Food Spending and Change Purchasing Patterns
New research published in the Journal of Marketing Research shows that GLP-1 receptor agonist drugs like Ozempic and Wegovy are significantl
news.cornell.edu·5mo ago
GLP-1 Drugs Linked to 30% Lower Breast Cancer Risk in New Study
New research published in the Journal of Clinical Oncology suggests GLP-1 weight loss medications may reduce cancer risk. An observational s
forbes.com·21d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.